XML 38 R31.htm IDEA: XBRL DOCUMENT v3.25.3
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 27, 2025
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation Expenses

The following table shows stock-based compensation expense included in the condensed consolidated statements of operations for the three and nine months ended September 27, 2025 and September 28, 2024 (in thousands):

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 27, 2025

 

 

September 28, 2024

 

 

September 27, 2025

 

 

September 28, 2024

 

Cost of revenues

 

$

7

 

 

$

68

 

 

$

46

 

 

$

201

 

Research and development

 

 

(31

)

 

 

25

 

 

 

32

 

 

 

129

 

Sales and marketing

 

 

5

 

 

 

(43

)

 

 

148

 

 

 

178

 

General and administrative

 

 

111

 

 

 

64

 

 

 

336

 

 

 

419

 

Total stock-based compensation expense

 

$

92

 

 

$

114

 

 

$

562

 

 

$

927

 

 

Summary of Stock Options

The following table summarizes stock options information during the nine months ended September 27, 2025:

 

 

 

Number of
Shares

 

 

Weighted
Average
Exercise Price
Per Share

 

 

Aggregate
Intrinsic
Value
(thousands)

 

Outstanding as of December 28, 2024

 

 

1,692,707

 

 

$

2.89

 

 

 

 

Granted

 

 

753,705

 

 

$

0.96

 

 

 

 

Canceled or forfeited

 

 

(263,992

)

 

$

3.90

 

 

 

 

Outstanding as of September 27, 2025

 

 

2,182,420

 

 

$

2.10

 

 

$

149

 

Weighted Average Assumptions for Fair Value Estimate of Stock-Based Awards (Options)

The Company uses the Black-Scholes option-pricing model to estimate the fair value of stock-based awards (options) with the following weighted-average assumptions:

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 27, 2025

 

 

September 28, 2024

 

 

September 27, 2025

 

 

September 28, 2024

 

Average risk free interest rate

 

 

3.63

%

 

 

4.35

%

 

 

3.82

%

 

 

4.35

%

Expected life (in years)

 

 

4.50

 

 

 

4.40

 

 

 

3.52

 

 

 

4.40

 

Dividend yield

 

 

 

 

 

 

 

 

Average volatility

 

 

69

%

 

 

77

%

 

 

76

%

 

 

77

%

Summary of Stock Options Outstanding, Vested, Expected to Vest and Exercisable

Information regarding stock options outstanding, vested, expected to vest, and exercisable as of September 27, 2025 is summarized below:

 

 

 

Number of
Shares

 

 

Weighted
Average
Exercise Price

 

 

Weighted
Average
Remaining
Contractual
Life (Years)

 

 

Aggregate
Intrinsic
Value
(thousands)

 

Options outstanding

 

 

2,182,420

 

 

$

2.10

 

 

 

3.77

 

 

$

149

 

Options vested and expected to vest

 

 

2,068,330

 

 

$

2.15

 

 

 

3.66

 

 

$

130

 

Options exercisable

 

 

1,221,342

 

 

$

2.79

 

 

 

2.81

 

 

$

1

 

Restricted Stock Units

Information regarding RSUs activity for the nine months ended September 27, 2025 is summarized below:

 

 

 

Number
of Shares

 

Outstanding as of December 28, 2024

 

 

615,707

 

Restricted stock units granted

 

 

176,258

 

Restricted stock units released

 

 

(169,220

)

Restricted stock units forfeited

 

 

(11,333

)

Outstanding as of September 27, 2025

 

 

611,412

 

 

Additionally, at the Company’s Annual Meeting held on June 11, 2025, the Company’s stockholders approved an amendment and restatement of the Company’s Restated Charter, among other matters, to increase the number of authorized shares of the Company’s common stock from 30,000,000 to 63,500,000 shares.